On February 29th of this year, within the framework of the EUROHELICAN project, the survey of participants in the GISTAR study ended in Cēsis. A total of 341 participants were surveyed in the research center in Cēsis, and so far - 1227 GISTAR participants in total.

The research is carried out within the framework of the international project "Accelerating gastric cancer reduction in Europe through H.pylori eradication" (EUROHELICAN for short). EUROHELICAN is a project supported by the EU program for EU health (EU4Health). within the framework, a population-based strategy for H.pylori testing and eradication will be evaluated. In Slovenia, H.pylori testing and eradication of the bacterium is carried out in the population group aged 30-34. Whereas in Latvia, based on previously conducted research, H.pylori testing and bacterium eradication is carried out analysis of the long-term impact of the eradication strategy.

The results obtained during the project will help experts to develop guidelines and policy makers to incorporate H.pylori testing and eradication strategy into healthcare priorities, thereby reducing the incidence of stomach cancer in Europe.

In Latvia, the project is implemented by the Institute of Clinical and Preventive Medicine of the University of Latvia (LU KPMI). Main cooperation partners: The National Institute of Public Health of Slovenia (The National Institute of Public Health - NIJZ), the International Agency for Research on Cancer of the World Health Organization (IARC/WHO France), Nantes University Hospital ( Nantes University Hospital, France) and Maribor Dr. Community Healthcare Center dr. Adolf Drolc Maribor, Slovenia. The project will continue until the end of April 2025.

More about the EUROHELICAN project - https://www.kpmi.lu.lv/petnieciba/petniecibas-projekti/eurohelican/

The views and opinions expressed here reflect the views of the author(s) only and do not reflect the position of the European Union or the European Health and Digital Executive Agency (HaDEA). The European Union and the funding authority are not responsible for them.

The project has received funding from the EU4Health program of the European Union in accordance with grant agreement no. 101079944